{"id":"W4399385857","doi":"10.1080/14728214.2024.2363213","title":"Emerging drugs for the treatment of benign prostatic hyperplasia: a 2023 update","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Université de Montréal","funders":"","keywords":"Medicine; Lower urinary tract symptoms; Hyperplasia; cGMP-specific phosphodiesterase type 5; Benign prostatic hyperplasia (BPH); Intensive care medicine; Primary care; Primary treatment; Modalities; 5 Alpha-Reductase Inhibitor; Urology; Prostate; Internal medicine; Gynecology; Erectile dysfunction; Finasteride; Cancer; Family medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005825481,0.0008576859,0.00211196,0.0006456884,0.0003170279,0.00007144905,0.0003632098,0.0002612941,0.0002448058],"category_scores_gemma":[0.00006268974,0.0004868195,0.001401412,0.0008010644,0.0001495511,0.00007424203,0.0001012318,0.0005128652,0.0002797435],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003971042,"about_ca_system_score_gemma":0.00076441,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009398223,"about_ca_topic_score_gemma":0.000001411227,"domain_scores_codex":[0.996038,0.0002084285,0.001117392,0.000963891,0.0008692466,0.0008030506],"domain_scores_gemma":[0.9973922,0.0008823532,0.000296247,0.001040134,0.0001507167,0.0002383073],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002052803,0.0004910086,4.868102e-7,0.01234681,0.001378835,0.0000253584,0.007074992,0.000002724897,0.000001952446,0.000498187,0.0351933,0.9427811],"study_design_scores_gemma":[0.001151742,0.001917679,2.988581e-7,0.0142924,0.0005830879,0.00006214869,0.001677907,0.0003556011,0.00002875516,0.00005761614,0.9794673,0.000405413],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00000566179,0.9873476,0.00004265258,0.003689446,0.002061163,0.005065924,0.0002964447,0.0001237327,0.001367352],"genre_scores_gemma":[0.00003170273,0.9885935,0.0002814324,0.0001109448,0.001315089,0.003004078,0.0009136848,0.0002421967,0.005507359],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9442741,"threshold_uncertainty_score":0.9997584,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07313921420710602,"score_gpt":0.4351080879869832,"score_spread":0.3619688737798772,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}